drugset / Trial / NCT03587584

Liposomal Bupivacaine Interscalene Blocks for Rotator Cuff Repair

NCT03587584 ↗

Phase 4 Completed 80 enrolled University of Minnesota
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare pain control after arthroscopic rotator cuff repair surgery using either liposomal bupivacaine or bupivacaine when injected in an interscalene block. Both medications, liposomal bupivacaine and bupivacaine, are standard of care in these types of surgeries.

Timeline

Start
2018-07-25
Primary completion
2021-05-25
Completion
2021-06-08

Outcome

Missed primary endpoint

paper LB added to bupivacaine interscalene blocks does not reduce opioid consumption within 72 hours following arthroscopic RCR. PMID 35190468 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 10 ml Other
Subject Bupivacaine Other / unclassified 20 ml Other
Subject Bupivacaine Other / unclassified 133 mg Other

Indications

No indication recorded.